ROCHE WILL BUY FLATIRON HEALTH FOR $1.9 BILLION

  Pharmaceutical giant Roche will buy New York City-based Flatiron Health. The Swiss company will pay $1.9 billion for Flatiron, adding to its existing stake of 12.6 percent in the startup. That makes the whole shebang worth about $2.1 billion. Officials…

BECTON, DICKINSON COMPLETES ACQUISITION OF C.R. BARD

Becton, Dickinson (BD) has completed the acquisition of C.R. Bard, creating a new healthcare company with approximately $16 billion in annualized revenue. Vincent A Forlenza, chairman and CEO, said the combined company builds on BD’s position in medication management and infection…

PRISM TRIAL EVALUATES SAFETY, EFFICACY OF INDIGO ASPIRATION SYSTE

Results of the multicenter PRISM trial were published by Richard R. Saxon, MD, et al in the  Journal of Vascular and Interventional Radiology (JVIR; 2018;29:92–100). PRISM evaluated the safety and initial efficacy of a power aspiration–based extraction technique for treatment of peripheral arterial…
0
    0
    Your Cart
    Your cart is emptyReturn to Ad Portal